chr1-34785351-G-A

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6

The NM_024009.3(GJB3):​c.589G>A​(p.Val197Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000719 in 1,613,358 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000073 ( 0 hom. )

Consequence

GJB3
NM_024009.3 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: -0.0260

Publications

3 publications found
Variant links:
Genes affected
GJB3 (HGNC:4285): (gap junction protein beta 3) This gene is a member of the connexin gene family. The encoded protein is a component of gap junctions, which are composed of arrays of intercellular channels that provide a route for the diffusion of low molecular weight materials from cell to cell. Mutations in this gene can cause non-syndromic deafness or erythrokeratodermia variabilis, a skin disorder. Alternative splicing results in multiple transcript variants encoding the same protein. [provided by RefSeq, Jul 2008]
SMIM12 (HGNC:25154): (small integral membrane protein 12) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07156438).
BP6
Variant 1-34785351-G-A is Benign according to our data. Variant chr1-34785351-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 46086.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GJB3NM_024009.3 linkc.589G>A p.Val197Ile missense_variant Exon 2 of 2 ENST00000373366.3 NP_076872.1 O75712A0A654ICK0
GJB3NM_001005752.2 linkc.589G>A p.Val197Ile missense_variant Exon 2 of 2 NP_001005752.1 O75712A0A654ICK0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GJB3ENST00000373366.3 linkc.589G>A p.Val197Ile missense_variant Exon 2 of 2 1 NM_024009.3 ENSP00000362464.2 O75712
GJB3ENST00000373362.3 linkc.589G>A p.Val197Ile missense_variant Exon 2 of 2 1 ENSP00000362460.3 O75712
SMIM12ENST00000426886.1 linkn.208-66942C>T intron_variant Intron 2 of 4 1 ENSP00000429902.1 E5RH51
ENSG00000255811ENST00000542839.1 linkn.110+2637C>T intron_variant Intron 1 of 1 5

Frequencies

GnomAD3 genomes
AF:
0.0000660
AC:
10
AN:
151576
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000485
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000195
Gnomad SAS
AF:
0.000418
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000736
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000477
AC:
12
AN:
251424
AF XY:
0.0000736
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000703
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000725
AC:
106
AN:
1461782
Hom.:
0
Cov.:
33
AF XY:
0.0000894
AC XY:
65
AN XY:
727192
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33478
American (AMR)
AF:
0.0000447
AC:
2
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0000927
AC:
8
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53352
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000773
AC:
86
AN:
1111974
Other (OTH)
AF:
0.0000994
AC:
6
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000660
AC:
10
AN:
151576
Hom.:
0
Cov.:
32
AF XY:
0.0000811
AC XY:
6
AN XY:
74012
show subpopulations
African (AFR)
AF:
0.0000485
AC:
2
AN:
41206
American (AMR)
AF:
0.00
AC:
0
AN:
15194
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000195
AC:
1
AN:
5126
South Asian (SAS)
AF:
0.000418
AC:
2
AN:
4788
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10562
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000736
AC:
5
AN:
67930
Other (OTH)
AF:
0.00
AC:
0
AN:
2074
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.520
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000823
Hom.:
0
Bravo
AF:
0.0000453
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0000247
AC:
3
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2
Jun 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 197 of the GJB3 protein (p.Val197Ile). This variant is present in population databases (rs376506263, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with GJB3-related conditions. ClinVar contains an entry for this variant (Variation ID: 46086). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GJB3 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Jul 18, 2017
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Val197Ile variant (rs376506263) has not been reported in the medical literature, nor has it been previously identified in our laboratory; however, it is listed in the ClinVar database (Variation ID: 46086). It is listed in the Genome Aggregation Database (gnomAD) browser with an overall frequency of 0.004% (identified in 11 out of 277,074 chromosomes). The valine at codon 197 is moderately conserved considering 13 species (Alamut software v2.9), and several species including Rhesus macaque have an isoleucine at this position, suggested this variant is evolutionary tolerated. Additionally, computational analyses suggest this variant does not have a significant effect on GJB3protein structure/function (SIFT: tolerated, PolyPhen2: benign, and Mutation Taster: polymorphism). However, based on the available information, the clinical significance of the p.Val197Ile variant cannot be determined with certainty. -

not specified Benign:1
Mar 04, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Val197Ile variant in exon 2 of GJB3: This variant is not expected to have clinic al significance due to lack of conservation across mammals and distant species. Of note, several mammals including primates (rhesus monkey and baboon) have an i soleucine (Ile) at this position. In addition, computational analyses (biochemic al amino acid properties, homology, PolyPhen2, SIFT, AlignGVGD) suggest the vari ant may not impact the protein. This variant has been identified in 1/8600 (0.01 %) European American chromosomes by the NHLBI Exome Sequencing Project (http:// evs.gs.washington.edu/EVS). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
6.0
DANN
Benign
0.76
DEOGEN2
Benign
0.41
T;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.22
N
LIST_S2
Benign
0.73
.;T
M_CAP
Benign
0.058
D
MetaRNN
Benign
0.072
T;T
MetaSVM
Benign
-0.42
T
MutationAssessor
Benign
0.27
N;N
PhyloP100
-0.026
PrimateAI
Benign
0.24
T
PROVEAN
Benign
0.34
N;N
REVEL
Uncertain
0.30
Sift
Benign
1.0
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.046
B;B
Vest4
0.039
MVP
0.50
MPC
0.057
ClinPred
0.015
T
GERP RS
0.76
Varity_R
0.039
gMVP
0.35
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs376506263; hg19: chr1-35250952; API